Safety & Side Effects of TMS Part 9:Building Trust Through Transparency in TMS Safety

---

---

One of the biggest challenges in mental health care isn’t just choosing a treatment—it’s trusting it. For many people considering Transcranial Magnetic Stimulation (TMS), the idea of using magnetic pulses on the brain can seem confusing or even intimidating at first. But when patients are met with honest information, clear communication, and compassionate care, that fear can quickly transform into confidence.

Transparency isn’t just a bonus in TMS care—it’s essential. It helps people feel informed, empowered, and safe as they begin a new form of therapy that, for many, represents hope after years of frustration.

Why Transparency Matters

Mental health treatments are deeply personal. Patients often arrive at a TMS clinic after months—or even years—of trying medications, therapy, or other interventions without success. Some are skeptical. Others are scared. Many are simply exhausted.

By being transparent from the start, providers can build trust and reduce anxiety, prevent misunderstandings about how TMS works, and create a partnership with the patient instead of a power dynamic.TMS works best when the patient is fully engaged—and people engage more when they feel respected, informed, and involved in the decision-making process.

Being Honest About Risks (Without Creating Fear)

Good providers don’t pretend that TMS is risk-free—but they put the risks into perspective. Patients should know:

• That mild side effects like headaches or scalp discomfort are common, but temporary
• That serious side effects, like seizures, are extremely rare (less than 1 in 30,000 treatments)
• That people with certain conditions or implants may not be eligible—but this is discovered during careful screening
• That the treatment is non-invasive, outpatient, and doesn’t involve anesthesia or sedation

When information is delivered openly, calmly, and clearly, it gives the patient room to process and ask questions without fear.

Showing the Data, Not Just Telling

Another way to build trust is by presenting real, digestible facts that patients can understand—not just vague reassurances. People want to know that TMS is based on solid research, recognized by medical authorities, and used by reputable clinics worldwide.

Here are some helpful facts to share that support safety, credibility, and effectiveness:

• FDA-approved since 2008 for major depression: TMS received clearance after rigorous testing and clinical trials showing it helped patients with treatment-resistant depression who hadn’t responded to medications.
• Expanded FDA approvals: In 2013, TMS was cleared for migraine with aura; in 2018, for OCD; and in 2020, for smoking cessation. These approvals show growing confidence in its broad therapeutic potential.
• Insurance coverage reflects credibility: TMS is now covered by most major insurance companies, including Medicare, Aetna, Cigna, UnitedHealthcare, and Blue Cross Blue Shield—for patients who meet standard clinical guidelines.
• Minimal risk of serious side effects: Less than 1 in 30,000 treatments results in a seizure—making it safer than many medications, even over-the-counter options in terms of risk profile.
• Used worldwide in hospitals and clinics: TMS is in use at major academic centers like Harvard, Mayo Clinic, Stanford, and Johns Hopkins, and in over 60 countries across Europe, Asia, and the Americas.
• 80%+ response rate in some clinic populations: Especially in personalized or “measurement-based” TMS approaches, some clinics report high response and remission rates for patients who complete a full course of treatment.
• Patients stay awake and alert: The treatment is so tolerable that patients often read, listen to music, or chat with staff while receiving care. There’s no anesthesia or recovery period required.
• Neuroplasticity-driven healing: TMS works by gently activating underactive brain circuits involved in mood, motivation, and focus. Over time, this promotes long-term changes in how the brain processes thoughts and emotions.

When facts like these are presented clearly—and without hype—they help ground patients in reality. TMS is not magic, and it’s not a miracle. But it is one of the most well-researched and safest non-invasive brain therapies available today, and people deserve to know that.

Listening Builds Trust, Too

Transparency isn’t just about facts—it’s also about being heard. Patients want to know that their fears, past experiences, and questions will be taken seriously. When providers take time to listen, check in frequently, and invite honest feedback during treatment, patients feel supported—not rushed or ignored.

This can be especially important for people who:

• Have had bad experiences with medications or mental health systems in the past
• Worry about being judged or dismissed
• Need reassurance that they can pause, ask questions, or even stop if something doesn’t feel right

When the treatment feels like a collaboration, not a lecture, patients are more likely to stick with it—and benefit from it.

A Safe Process is a Shared Process

TMS safety isn’t just built on technology or protocol—it’s built on people. Providers who are transparent about risks, realistic about benefits, and responsive to individual concerns create a foundation of trust that leads to better outcomes and better experiences.

Patients don’t have to know everything about the science of TMS—but they deserve to know enough to feel in control of their care. When clinics are open, honest, and human in their approach, patients don’t just feel safe—they feel respected.

Sources

1. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE 3rd, Schwartz T, Sackeim HA. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May;67(5):507-16. doi: 10.1001/archgenpsychiatry.2010.46. PMID: 20439832.
2. McClintock, S. M., et al. (2018). Consensus recommendations for clinical application of rTMS in depression. Journal of Clinical Psychiatry, 79(1), 16cs10905. https://doi.org/10.4088/JCP.16cs10905
3. Brunoni, A. R., et al. (2017). Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: A systematic review with network meta-analysis. JAMA Psychiatry, 74(2), 143–152. https://doi.org/10.1001/jamapsychiatry.2016.3644
4. Carpenter, L. L., Aaronson, S. T., Hutton, T. M., Mina, M., Pages, K., Verdoliva, S., West, W. S., & Sackeim, H. A. (2021). Comparison of clinical outcomes with two transcranial magnetic stimulation treatment protocols for major depressive disorder. Brain Stimulation, 14(1), 173–180. https://pubmed.ncbi.nlm.nih.gov/33346068/

Locations

Choose the office that’s most convenient for you. Our Chesterfield and Richmond Heights locations are here to provide accessible, patient-focused care in a welcoming and professional environment.

CHESTERFIELD
112 Chesterfield Commons East Rd.
Chesterfield, MO 63005
314-697-4867

RICHMOND HEIGHTS
1505 S Big Bend Blvd,
Richmond Heights, MO 63117
314-384-1006